Recursion Pharmaceuticals, Inc. (RXRX)
3.70
+0.12
(+3.35%)
USD |
NASDAQ |
Oct 23, 16:00
3.67
-0.03
(-0.81%)
After-Hours: 20:00
Recursion Pharmaceuticals Price : 3.70 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 3.52 | 3.70 | 3.45 | 3.70 | 19.08M |
| Oct 22, 2026 | 3.54 | 3.68 | 3.485 | 3.58 | 17.74M |
| Oct 21, 2026 | 3.66 | 3.76 | 3.56 | 3.64 | 19.36M |
| Oct 20, 2026 | 3.555 | 3.67 | 3.47 | 3.66 | 20.93M |
| Oct 19, 2026 | 3.53 | 3.69 | 3.48 | 3.61 | 30.01M |
| Oct 16, 2026 | 4.11 | 4.185 | 3.44 | 3.465 | 40.72M |
| Oct 15, 2026 | 3.65 | 4.41 | 3.53 | 4.16 | 62.87M |
| Oct 14, 2026 | 3.72 | 3.91 | 3.66 | 3.74 | 18.78M |
| Oct 13, 2026 | 4.01 | 4.05 | 3.82 | 3.835 | 19.76M |
| Oct 12, 2026 | 4.31 | 4.365 | 3.91 | 4.01 | 23.79M |
| Oct 09, 2026 | 4.015 | 4.43 | 3.89 | 4.36 | 35.50M |
| Oct 08, 2026 | 4.19 | 4.20 | 3.79 | 3.95 | 30.90M |
| Oct 07, 2026 | 4.505 | 4.60 | 4.23 | 4.27 | 40.73M |
| Oct 06, 2026 | 4.81 | 5.19 | 4.395 | 4.63 | 71.11M |
| Oct 05, 2026 | 4.16 | 4.935 | 4.060 | 4.78 | 67.28M |
| Oct 02, 2026 | 4.18 | 4.27 | 4.01 | 4.12 | 18.84M |
| Oct 01, 2026 | 4.07 | 4.17 | 3.96 | 4.07 | 17.48M |
| Sep 30, 2026 | 4.09 | 4.29 | 3.98 | 4.13 | 32.79M |
| Sep 29, 2026 | 3.73 | 4.04 | 3.722 | 4.03 | 21.56M |
| Sep 28, 2026 | 3.69 | 3.840 | 3.665 | 3.70 | 13.06M |
| Sep 25, 2026 | 3.89 | 3.90 | 3.70 | 3.74 | 10.48M |
| Sep 24, 2026 | 3.65 | 3.90 | 3.61 | 3.89 | 19.34M |
| Sep 23, 2026 | 4.03 | 4.09 | 3.66 | 3.70 | 23.67M |
| Sep 22, 2026 | 4.00 | 4.16 | 3.90 | 4.05 | 40.46M |
| Sep 21, 2026 | 3.92 | 4.015 | 3.83 | 3.97 | 37.73M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Absci Corp. | 9.18 |
| Twist Bioscience Corp. | 139.92 |
| Editas Medicine, Inc. | 2.40 |
| Intellia Therapeutics, Inc. | 11.21 |
| Amgen, Inc. | 439.26 |
Price Related Metrics
| PS Ratio | 34.32 |
| Price to Book Value | 2.160 |
| Earnings Yield | -28.01% |
| Market Cap | 1.976B |